nach oben

Erschienen in:

01.09.2020 | Clinical study

Cost effectiveness of screening for drug-induced liver injury

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Paper-based point-of-care testing appears to be the most cost-effective screening strategy for identifying drug-induced liver injury (DILI) due to antiretroviral and antitubercular therapy in patients with HIV/AIDS and tuberculosis (TB) in low- and middle-income countries (LMICs), according to findings of a study published in Clinical Infectious Diseases. …

Moed S, et al. Economic Evaluation of Screening Interventions for Drug Induced Liver Injury. Clinical Infectious Diseases : 8 Sep 2020. Available from: URL: http://doi.org/10.1093/cid/ciaa1347

Titel: Cost effectiveness of screening for drug-induced liver injury
Publikationsdatum: 01.09.2020
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-83361-0

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Cost effectiveness of screening for drug-induced liver injury

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Abacavir/lamivudine/lopinavir/ritonavir

Empagliflozin

Unspecified low-molecular-weight-heparins/warfarin

Bicarbonate

Atorvastatin

Rabies vaccine